Elizabeth J Phillips Selected Research

COVID-19

11/2023	An Update in COVID-19 Vaccine Reactions in 2023: Progress and Understanding.
1/2023	Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit.
1/2023	Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis.
1/2023	Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
1/2022	A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies.
1/2022	Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity.
1/2022	COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA.
1/2022	Adverse Events and Safety of SARS-CoV-2 Vaccines: What's New and What's Next.
12/2021	DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing.
2/2021	DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth J Phillips Research Topics

Disease

83	Hypersensitivity (Allergy) 05/2024 - 03/2002
16	Anaphylaxis (Anaphylactic Shock) 05/2024 - 07/2014
16	Drug Hypersensitivity (Drug Allergy) 01/2023 - 06/2009
15	Drug-Related Side Effects and Adverse Reactions 01/2022 - 12/2002
11	COVID-19 11/2023 - 01/2020
9	Drug Hypersensitivity Syndrome 01/2024 - 01/2017
8	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2024 - 06/2009
8	Infections 01/2022 - 03/2016
7	Exanthema (Rash) 04/2024 - 03/2002
7	Immediate Hypersensitivity 01/2024 - 05/2019
7	Neoplasms (Cancer) 01/2021 - 03/2002
6	Cicatrix (Scar) 04/2024 - 07/2018
6	Chemical and Drug Induced Liver Injury 03/2024 - 01/2013
6	Delayed Hypersensitivity (Hypersensitivity, Type IV) 06/2022 - 01/2020
4	Thrombocytopenia (Thrombopenia) 01/2023 - 09/2017
3	red meat allergy 01/2024 - 01/2017
3	Communicable Diseases (Infectious Diseases) 01/2021 - 09/2016
3	Fever (Fevers) 08/2014 - 03/2002
2	Asthma (Bronchial Asthma) 05/2024 - 11/2022
2	Blister (Bulla) 02/2024 - 01/2018
2	Parkinson Disease (Parkinson's Disease) 02/2024 - 01/2019
2	Myocarditis (Carditis) 11/2022 - 11/2016
2	Hypertension (High Blood Pressure) 10/2022 - 09/2005
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 09/2005
2	Acute Generalized Exanthematous Pustulosis 01/2021 - 03/2003
2	Neutropenia 01/2021 - 03/2002
2	Angioedema 10/2020 - 01/2020
2	Chronic Disease (Chronic Diseases) 07/2019 - 01/2003
2	HIV Infections (HIV Infection) 11/2017 - 01/2003
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2016 - 01/2003
1	Food Hypersensitivity (Food Allergy) 05/2024
1	Necrosis 04/2024
1	Gram-Positive Bacterial Infections 01/2024
1	Inflammation (Inflammations) 10/2023

Drug/Important Bio-Agent (IBA)

37	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 12/2002
26	Penicillins (Penicillin)FDA Link 01/2023 - 01/2017
20	abacavir (Ziagen)FDA Link 01/2022 - 11/2002
15	VaccinesIBA 05/2024 - 03/2016
14	HLA-B Antigens (HLA-B)IBA 12/2022 - 06/2007
12	HLA Antigens (Human Leukocyte Antigens)IBA 04/2024 - 06/2007
12	COVID-19 VaccinesIBA 11/2023 - 01/2021
7	Immunoglobulin E (IgE)IBA 01/2024 - 07/2014
7	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
7	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023 - 01/2020
7	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 05/2019
6	Vancomycin FDA LinkGeneric 01/2024 - 01/2019
6	beta-LactamsIBA 06/2022 - 12/2018
6	HLA-B57 antigenIBA 01/2022 - 01/2014
5	AntigensIBA 04/2024 - 02/2008
5	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2022 - 12/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 02/2022
4	Peptides (Polypeptides)IBA 01/2023 - 01/2017
4	SulfonamidesIBA 01/2023 - 12/2002
4	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 09/2017
4	LactamsIBA 01/2021 - 12/2019
4	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021 - 06/2009
4	EnzymesIBA 01/2021 - 07/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 01/2018
3	AntibodiesIBA 01/2024 - 01/2022
3	GlycopeptidesIBA 01/2024 - 01/2021
3	HLA-A Antigens (HLA-A)IBA 01/2024 - 01/2019
3	mRNA VaccinesIBA 01/2023 - 01/2022
3	Excipients (Suspending Agents)IBA 01/2023 - 01/2021
3	Platelet Factor 4IBA 01/2023 - 01/2022
3	Immune Checkpoint InhibitorsIBA 11/2022 - 11/2016
2	CytokinesIBA 04/2024 - 01/2020
2	AnticoagulantsIBA 01/2023 - 01/2022
2	Therapeutic UsesIBA 10/2022 - 09/2017
2	pegaspargase (Oncaspar)FDA Link 01/2022 - 01/2022
2	TeaIBA 01/2022 - 01/2021
2	Pseudoephedrine FDA LinkGeneric 12/2021 - 02/2021
2	turmeric extractIBA 12/2021 - 02/2021
2	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 12/2021 - 02/2021
2	Ibuprofen (Motrin)FDA LinkGeneric 12/2021 - 02/2021
2	Estradiol (Delestrogen)FDA LinkGeneric 12/2021 - 02/2021
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2021 - 02/2021
2	Fluticasone (Cutivate)FDA LinkGeneric 12/2021 - 02/2021
2	KIR ReceptorsIBA 01/2021 - 09/2017
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2021 - 01/2019
2	Thymidine Monophosphate (TMP)IBA 01/2021 - 12/2002
2	EpitopesIBA 11/2017 - 03/2016
2	Nevirapine (Viramune)FDA Link 01/2017 - 02/2008
2	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 06/2009
2	Allopurinol (Remid)FDA LinkGeneric 03/2011 - 06/2009
2	Clindamycin (Cleocin)FDA LinkGeneric 12/2005 - 03/2003
1	Immunologic Factors (Immunomodulators)IBA 04/2024
1	Janus KinasesIBA 04/2024
1	Amikacin (A.M.K)FDA LinkGeneric 04/2024
1	Neomycin FDA LinkGeneric 04/2024
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2024
1	ProteomeIBA 02/2024
1	Proteins (Proteins, Gene)FDA Link 02/2024
1	alpha-SynucleinIBA 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 01/2024
1	Immunoglobulin G (IgG)IBA 01/2024
1	Immunoglobulin M (IgM)IBA 01/2024

Therapy/Procedure

13	Therapeutics 01/2024 - 03/2002
3	Immunotherapy 11/2022 - 11/2016
2	Drug Therapy (Chemotherapy) 01/2023 - 12/2019
2	Critical Care (Surgical Intensive Care) 01/2022 - 09/2005